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Abstract
MicroRNAs are involved in post-transcriptional down-regulation of gene expression. Variations in miRNA genes can severely
affect downstream-regulated genes and their pathways. However, population-specific burden of CNVs on miRNA genes and
the complexities created towards the phenotype is not known. From a total of 44109 CNVs investigated from 1715
individuals across 12 populations using high-throughput arrays, 4007 miRNA-CNVs (,9%) consisting 6542 (,5%) miRNA
genes with a total of 333 (,5%) singleton miRNA genes were identified. We found miRNA-CNVs across the genomes of
individuals showing multiple hits in many targets, co-regulated under the same pathway. This study proposes four
mechanisms unraveling the many complexities in miRNA genes, targets and co-regulated miRNA genes towards
establishment of phenotypic diversity.
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Introduction
Copy Number Variations (CNVs) are a segment of DNA of .
1 kb with a variable copy number compared with the reference
genome [1]. CNVs are a widespread and common phenomenon
among humans [2,3] and no single human without CNVs has yet
been identified. CNV occurrence can be limited to a single gene or
a contiguous set of genes and results in dosage-sensitiveness, which
may contribute significantly towards human phenotypic variabil-
ity, complex behavioral traits and disease susceptibility. CNVs in
one or more genes can cause functional loss, either by disrupting a
regulatory element, generating novel fusion products, or through
position effect, with various possible outcomes, including imprint-
ing and differential allelic expression [4].
CNVs are prevalent in both coding and non-coding regions of
the genome encompassing both genes and regulatory regions.
These coding regions also contain MicroRNAs (miRNA) genes
across all chromosomes and makes up about 4% of the coding
genes. miRNAs are ,22 base small RNA sequences, derived from
the pre-transcript of ,70–120 bases that affect significant
biological processes by repressing the translation of coding genes
by binding to specific sequence in the 39UTR of target genes [5].
These miRNA genes regulate the production of protein for .30%
of all human coding genes [6]. Over expression of certain miRNA
genes is found to contribute towards cancer and other diseases [7],
and some miRNAs have multiple mRNA targets, and some of
these targets are also regulated by multiple miRNAs [8]. miRNAs
are involved in crucial biological processes, including develop-
ment, differentiation, apoptosis and proliferation, through imper-
fect pairing with target mRNAs of protein-coding genes and the
transcriptional or post-transcriptional regulation of their expres-
sion [9].
CNVs in miRNA genes affect binding and regulation of miRNA
target genes [10]. CNV-miRNAs are involved in many processes
and diseases, including organ development, angiogenesis, and
male fertility. CNV-miRNAs are known to form regulatory loop
for several transcripts and downstream target genes and the
miRNAs present in deleted and duplicated CNV loci alter the
dosage of the crucial genes by impairing the processing miRNAs
by targeting key molecules [11]. Previous CNV-miRNA studies
have been performed on HapMap genomes [9,12] without
providing population specific CNV-miRNA distribution and only
reasoned the genotypic complexities contributed by the CNVs on
miRNA subjectively.
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miRNAs act by modulating gene expression by inhibiting the
translation and facilitating the degradation of their targeted
mRNAs, and these are found aberrantly expressed in many
diseases including cancer, and such studies have concentrated only
on the genotypic complexities involving either miRNA genes or its
target genes, and have failed to collectively analyze the complex-
ities in the individual genomes [13–15]. In the present investiga-
tion, we have made an attempt to identify the CNV burden on
miRNA genes across 12 populations which report the first drafts of
population-specific CNV-miRNA maps and provide several layers
of genotypic complexities and phenotypic expressions.
Materials and Methods
For this study, a total of 1715 individuals involving 43 normal
members from randomly selected twelve families residing in
Karnataka, India with different age group members ranging from
13–73 years, 270 HapMap samples covering CEU (CEPH
collection), CHB (Han Chinese in Beijing, China), JPT (Japanese
in Tokyo, Japan) and YRI (Yoruba in Ibadan, Nigeria) popula-
tions, 31 Tibetan samples, 155 Chinese samples, 472 of Ashkenazi
Jews replicate 1, 480 of Ashkenazi Jews replicate 2, 204 individuals
from Taiwan, 55 from Australia and 64 from New World
population (Totonacs and Bolivians), were selected for the CNV
analysis in the genome. The 270 individuals sample data from the
four populations was obtained from the International HapMap
Consortium [16]. The samples for the HapMap come from a total
of 270 people: the 30 both-parent-and-adult-child trios from the
Yoruba people in Ibadan, Nigeria, 45 unrelated Japanese
individuals in Tokyo, 45 unrelated individuals Han Chinese in
Beijing, and the 30 both-parent-and-adult-child trios from CEPH.
The raw, unprocessed data from Affymetrix Genome Wide SNP
6.0 array for the 31 individuals of Tibet population was obtained
from the ArrayExpress Archive at the European Bioinformatics
Institute to identify regions of the genome that have undergone
positive selection in a high-altitude Tibetan population. The
following datasets were obtained from the ArrayExpress archive
with the accession numbers E-GEOD-21661, E-GEOD-29851, E-
GEOD-30481, E-GEOD-15826, E-GEOD-23636, E-GEOD-
23201, E-GEOD-33355 and E-GEOD-33356. Data has been
made publicly accessible through the University of Mysore
Genome Centre Database (URL: http://umgc.uni-mysore.ac.in/
index.php/search/cnv).
5ml EDTA blood was collected from each member of the
Indian study group and genomic DNA was extracted using
Promega Wizard Genomic DNA purification kit. The isolated
DNA was quantified by Bio-photometer and gel electrophoresis.
This research was approved by the University of Mysore
Institutional Human Ethics review committee (IHEC). Written
informed consent was obtained from all sample donors and the
IHEC approved the sample consent procedure. Written informed
Figure 1. Map of miRNA genes in different chromosomes across populations. Each color coded vertical line represents a single population.
doi:10.1371/journal.pone.0090391.g001
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consent was obtained from parents/guardians in the cases of
participants being minors.
Genotyping
Genome-wide genotyping was performed using an Affymetrix
Genome-wide Human SNP Array 6.0 chip and Affymetrix
CytoScan High-Density (HD) Array having 1.8 million and
2.6 million combined SNP and CNV markers with the median
inter- marker distance of 500–600 bases. These chips provide
maximum panel power and the highest physical coverage of the
genome [17]. Genotyping quality was assessed using Affymetrix
Genotyping Console Software. Copy Number Analysis Method
offers two types of segmenting methods, univariate and multivar-
iate. These methods are based on the same algorithm, but use
different criteria for determining cut-points denoting CNV
boundaries.
Algorithms for Copy Number state calling
BirdSuite (v2). BirdSuite [18] is a suite originally developed
to detect known common CNPs based on prior knowledge, as well
as to discover rare CNVs, from Affymetrix SNP 6.0 array data. To
do this, it incorporates two main methods; the ‘‘Birdsuite’’
algorithms and the‘‘Canary’’ [19]. The Birdsuite algorithm uses
a Hidden Markov model (HMM) approach to find regions of
variable copy number in a sample. For the HMM, the hidden state
is the true copy number of the individual’s genome and the
observed states are the normalized intensity measurements of each
array probe. CNV calls from the Canary and Birdsuite algorithms
were collated for each sample, and kept as long as they met the
following criteria: i) Birdsuite calls with a log10 of odds (LOD)
score (Odds Ratio) greater than or equal to 10 (corresponding to
an approximate False Discovery Rate of ,5%), ii) Birdsuite calls
with copy number states other than 2 were retained; iii) Canary
CNP calls with CN states different from the population mode were
retained.
CNVFinder. CNVFinder developed at the Welcome Trust
Sanger Institute uses a dynamic, multiple-threshold based
approach to allow robust classification of copy number changes
in data of varying qualities. This algorithm makes two main
assumptions i) that the majority of data points are normally
distributed around a log2 ratio of zero, and ii) that data points
falling outside of the centralized log2 ratio distribution are
representative of a difference in copy number between test and
reference genome.
Canary. CNP analysis was performed using the Canary
algorithm. Canary was developed by the Broad Institute for
making copy number state calls in genomic regions with CNPs.
Canary algorithm computes a single intensity summary statistic
using a subset of manually selected probes within the CNP region.
The intensity summaries are compared in aggregate across all
samples to intensity summaries previously observed in training
data to assign a copy number state call.
Figure 2. Distribution of miRNA CNVs and genes across 12 populations. a) Represents distribution of miRNA and non-miRNA CNV types b)
represents burden of miRNA genes under duplication and deletion CNVs; c) represents mean duplication and deletion CNV size; d) represents the
percent distribution of singleton miRNA gene.
doi:10.1371/journal.pone.0090391.g002
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Genotyping Console
After processing CEL files and the Birdseed to call genotypes,
we used the Genotyping Console (GTC v.3.0.2) to detect CNVs
from the Affymetrix 6.0 array for samples that passed initial QCs.
The default parameters of .1 Kb size and .5 probes in this
algorithm were used.
Data Analysis
Genome-wide CNV study was carried out using SVS Golden
Helix Ver. 7.2 [20] and Affymetrix Genotyping Console software
as prescribed in their manuals [21–23]. Eigenstrat method was
used to avoid possibility of spurious associations resulting from
population stratification. Bonferroni correction was employed for
multiple testing and the corrected data were then used for CNV
testing. Bonferroni methods for population data genotyped on the
Affymetrix 6.0 platform was a=0.05 thresholds between 161027
and 761028.
Analyzing the collated data from both BirdSuite and Canary
algorithms increased the stringency on those meeting the CNP
calls with a log10 of odds score greater than or equal to 10
corresponding to a False Discovery Rate of ,5%. All SNPs that
were called using Birdseed v2algorithm had a Quality Control
(QC) call rate of .97% across individuals. All the subjects and
members with SNPs that passed SNP QC procedures were
entered into the CNV analysis. Filters were set for ID call rates for
the overall SNPs to identify IDs with poor quality DNA, if any.
The CNV calls were generated using the Canary algorithm. In
AGCS, contrast QC has to be .0.4 to be included in the CNV
analyses. In this study, contrast QC observed was .2.5 across all
samples showing a robust strength. To control for the possibility of
spurious or artifact CNVs, we used the EIGENSTRAT approach
of Price et al., [24]. This method derives the principal components
of the correlations among gene variants and corrects for those
correlations in the testing. We removed 55 individuals from the
study group because they were extreme outliers on one or more
significant EIGENSTRAT axes and further dropped 543 CNVs in
the members selected for the study for not meeting the required
QC measures. CNVs were considered validated when there was a
reciprocal overlap of 50% or greater with the reference set.
Though the Jaccard statistic is sensitive to the number of CNVs
called by each algorithm (ideally each two algorithms would detect
similar number of CNV calls), the relative values between the
different comparisons of algorithms/platform/site are very infor-
mative. All the overlap analyses performed have handled losses
and gains separately except when otherwise stated, and were
conducted hierarchically. The calls from the algorithms that were
called in both were not considered; instead, they were collated so
that the relative values between the different comparisons of
algorithms/platform/site are still very informative.
HD-CNV
In order to compare and identify CNV-miRNA between
samples of the same and other population as hotspots and rare,
and to also correlate their abeyant effects on a wide variety of
Figure 3. Copy Number State and Sex bias in miRNA sub-genome. a) Distribution of copy number states of the miRNA CNVs across 12
populations; b) represents the mean CN state across populations and c) represents the male-female distribution of miRNA genes under CNVs.
doi:10.1371/journal.pone.0090391.g003
CNV Burden on miRNA Genes
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biological contexts, HD-CNV [25] (Hotspot Detector for Copy
Number Variants), was used to analyze and detect recurrent CNV
regions by finding cliques in an interval graph generated from the
input. HD-CNV requires CNV calls as an input to detect
recurrent regions based on percentage overlap. Here, CNV events
are treated as nodes in an interval graph and are used to represent
regions (intervals) on a real line, and edges are added where
intervals overlap as postulated by Lekkerkerker et al. [26]. Based
on this, Butler et al. [25], modified and added edges between
nodes that share the base pair overlap required to consider two
CNV events part of a merged region (default 40%) and the overlap
required for a family (region with highly similar CNV events,
default 99%). Merged regions, therefore, contain a collection of
CNV events where each overlaps all others in the merged region
by the minimum overlap specified, and indicate the genomic
location where those groups of overlapping CNVs are found. [25].
The output graph generated by the HD-CNV was then visualized
using Gephi graph creation software.
Generation of CNV map
The shared map of 6542 miRNA genes under CNVs across all
chromosomes was generated using the Circos software package
[27].
Breakpoint Validations
To validate some of the identified miRNA-CNV breakpoints
from this study, PCR was performed on 400 randomly chosen
individuals for 4 miRNA-CNV breakpoints. A chimeric primer
flanking normal and deleted/duplicated sequence was designed so
as to bind only to the miRNA-CNV breakpoints. Samples that do
not contain these specific miRNA-CNVs, would fail to amplify.
PCR amplification was performed at 95uC for 39 followed by 35
cycles of 94uC for 3099, 62u–68uC for 3099, and 72uC for 59 in
Kyratec PCR System (Kyratec, Australia). All PCR products were
analyzed on 1% agarose gels and documented with a Vilber
Lourmat Imaging system (Vilber Lourmat, France).
Results
We identified a total of 44109 CNVs investigated from 1715
individuals across 12 populations. These CNVs contain 126190
genes consisting of 15185 singleton genes. Of these, 4007 miRNA-
CNVs (,9%) contained 6542 (,5%) miRNA genes with a total of
333 (,5%) singleton miRNA genes. These miRNA-CNVs were
identified in 1438 (,83.8%) individuals with a mean of 4.5
miRNA genes (Table 1) (Figure 1). miRNA-CNVs were found
ranging from 3–11% across all populations with Taiwan,
Ashkenazi Jews and Australia showing .8% while the remaining
populations were found between 4–7% and YRI with only 3%.
Duplication CNVs containing miRNA genes was significantly
higher (87.6%) compared to deletion (12.4%). However, HapMap
populations excluding YRI showed higher miRNA deletion CNVs
than duplication CNVs. The duplication miRNA-CNVs were in
the range of 81–91% with highest in Ashkenazi Jews (91.6%) and
lowest in CHB (36.8%). The deletion miRNA-CNVs were found
highest and lowest in CHB (63.1%) and Tibet (5.6%) respectively.
Chromosome-wise distribution of miRNA-CNVs
Chromosome 22 showed the highest CNV burden on miRNA
genes across all populations (Figure S1a). Chromosomes 15 and 16
further showed the mean burden at ,9% and 11%, with
Ashkenazi Jews and JPT showing heavy burden. There were few
instances without miRNA-CNV presences in chromosome, for
populations such as CHB and Tibet showing no CNV presences in
chromosome 15, whereas, chromosome 16 showed miRNA-CNV
presences for all populations. Chromosomes 13, 5 and 6 showed
negligible presence of miRNA-CNVs for all populations, popula-
tion specific miRNA-CNVs presence or absences were also
observed (Figure S1a).
Figure 4. CNV miRNA pathway showing the CNV burden of miRNA genes and its interaction with target proteins indicating the
involvement in biological functions and diseases.
doi:10.1371/journal.pone.0090391.g004
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Table 3. Functional and disease association annotation of the miRNA genes under the CNV burden.
Category Functions Annotation p-Value Molecules
Cardiovascular Disease DiGeorge syndrome 2.52E-05 mir-1286, mir-650
Congenital Heart Anomaly DiGeorge syndrome 2.52E-05 mir-1286, mir-650
Developmental Disorder DiGeorge syndrome 2.52E-05 mir-1286, mir-650
Hereditary Disorder DiGeorge syndrome 2.52E-05 mir-1286, mir-650
Inflammatory Disease Lupus nephritis 6.85E-05 miR-3118, miR-657, TNF
Hereditary Disorder Harboyan syndrome 6.99E-04 SLC4A11
Ophthalmic Disease Harboyan syndrome 6.99E-04 SLC4A11
Developmental Disorder Congenital hereditary endothelial dystrophy, ched 2 6.99E-04 SLC4A11
Hereditary Disorder Congenital hereditary endothelial dystrophy, ched 2 6.99E-04 SLC4A11
Ophthalmic Disease Congenital hereditary endothelial dystrophy, ched 2 6.99E-04 SLC4A11
Inflammatory Disease Cytomegalovirus colitis 6.99E-04 TNF
Gastrointestinal Disease Cytomegalovirus colitis 6.99E-04 TNF
Infectious Disease Cytomegalovirus colitis 6.99E-04 TNF
Organismal Injury and Abnormalities Deformation of tail 6.99E-04 TNF
Ophthalmic Disease Fuchs endothelial corneal dystrophy type 4 6.99E-04 SLC4A11
Skeletal and Muscular Disorders Inflammation of cremaster muscle 6.99E-04 TNF
Connective Tissue Disorders Insulin resistance of white adipocytes 6.99E-04 TNF
Endocrine System Disorders Insulin resistance of white adipocytes 6.99E-04 TNF
Metabolic Disease Insulin resistance of white adipocytes 6.99E-04 TNF
Hereditary Disorder Pseudoxanthoma elasticum-like disorder with multiple coagulation factor
deficiency
6.99E-04 GGCX
Connective Tissue Disorders Pseudoxanthoma elasticum-like disorder with multiple coagulation factor
deficiency
6.99E-04 GGCX
Cancer Transformation of dendritic precursor cells 6.99E-04 TNF
Inflammatory Disease Multiple Sclerosis 9.20E-04 C6orf15, miR-3612, TNF
Skeletal and Muscular Disorders Multiple Sclerosis 9.20E-04 C6orf15, miR-3612, TNF
Neurological Disease Multiple Sclerosis 9.20E-04 C6orf15, miR-3612, TNF
Neurological Disease Progressive motor neuropathy 1.08E-03 C6orf15, miR-338-3p, miR-
3612, TNF
Developmental Disorder Congenital combined deficiency of vitamin K-dependent coagulation factors 1.40E-03 GGCX
Hematological Disease Congenital combined deficiency of vitamin K-dependent coagulation factors 1.40E-03 GGCX
Immunological Disease Delay in formation of granuloma 1.40E-03 TNF
Liver Damage Hepatotoxicity of hepatocytes 1.40E-03 TNF
Dermatological Diseases and Conditions Non-melanoma skin cancer 2.10E-03 TNF
Hepatic System Disease Hepatitis subtype infantile hepatitis syndrome 2.79E-03 TNF
Liver Inflammation/Hepatitis Hepatitis subtype infantile hepatitis syndrome 2.79E-03 TNF
Psychological Disorders Scrapie of lymph node 2.79E-03 TNF
Drug Metabolism Stimulation of hyaluronic acid 2.79E-03 TNF
Renal and Urological Disease Unilateral ureteral obstruction 2.79E-03 TNF
Skeletal and Muscular Disorders Wasting of skeletal muscle 2.79E-03 TNF
Nutritional Disease Wasting of skeletal muscle 2.79E-03 TNF
Kidney Failure Acute renal failure 7.09E-02 TNF
Liver Fibrosis Fibrosis of liver 1.14E-01 TNF
Liver Cirrhosis Cirrhosis 1.53E-01 TNF
Heart Failure Heart failure 2.29E-01 TNF
Hepatocellular Carcinoma Hepatocellular carcinoma 3.36E-01 TNF
doi:10.1371/journal.pone.0090391.t003
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miRNA Gene concentration in duplication and deletion
regions
miRNA genes were found overrepresented in duplication
regions in eight populations, and deletion regions in three
populations and near to equal ratios in only one population.
The highest gene content under duplication CNVs was observed
for Australia and Ashkenazi Jews, followed by India, Taiwan and
Tibet (Table 1). The highest gene content under deletion CNVs
was observed in Chinese populations (CHB-80%, China-66.6%)
and JPT (57%) (Figure 2b). miRNA-CNV size across population
revealed contrasting distribution compared to CNV occurrence
showing significant contribution from sizes of deletion CNV than
duplication. The highest deletion CNV size was observed for eight
populations and equal ratios of miRNA gene were observed in
both duplication and deletion regions only for JPT. Ashkenazi
Jews and Taiwan populations showed heavy burden of CNV size
on miRNA genes with a mean CNV size ranging from 400–
700 kb, while the miRNA-CNVs of the remaining populations
ranged anywhere between 200–400 kb (Figure 2c). While the
former was due to both duplication as well as deletion miRNA-
CNVs, the latter was burdened by only the deletion miRNA-
CNVs.
Of the total miRNA singleton genes under CNVs Ashkenazi
Jews, JPT and Taiwan showed the highest number (7–11%) while
Africa and New World populations showed the lowest number
(Figure 2d). First glances of total miRNA gene distribution across
chromosomes revealed 22nd chromosome to contain large number
(30–60%) of miRNA genes under CNVs, however, singleton
miRNA gene distribution across chromosomes revealed otherwise
(,10%). This disparity was observed due to the consistent
frequenting of CNVs in the regions bearing mir-650 gene across
all populations and not due to multiple genes (Figure S1b). This
type of disparity between the distributions of total genes and
singleton miRNA genes was also observed across chromosomes
within the populations (Figure S2a–b).
Copy Number (CN) State of miRNA sub-genome
CN states for all duplication and deletion miRNA-CNVs were
assessed based on the 0, 1, 2, 3 and 4 states, where the numerical
value represents its corresponding allele presence in the genome.
HapMap and China showed complete removal of both allelic
segments (CN=0) in the genome (18–45%) for some miRNA
genes. Taiwan, Ashkenazi Jews, India, Australia and Tibet showed
a further loss of one allele state in the miRNA gene bearing regions
(,11%). Nearly all populations showed a high number of CN=3
autosomal duplication miRNA- CNVs ranging from 58–80%. The
homozygous duplication (CN=4) state was seen across all
populations distinctly, Ashkenazi Jews, China, Taiwan and New
World showed the highest dual duplication CN state (3–5%)
(Figure 3a). Inclusive analyses of all the 5 CN states showed
increased losses of miRNA sub-genome in CHB, JPT, CEU,
China, YRI and on the contrary Tibet, Ashkenazi Jews, Australia,
New World, India and Taiwan showed significant overall gains,
while CN state in the miRNA genes of sex chromosomes (CN=2)
was observed only for Australia. Mean CN state across all
populations ranged from 1.6–3.7. The CN state of two populations
(CHB and JPT) were ,2 while the remaining populations varied
between 2–3 (Figure 3b).
Sex bias in miRNA-CNVs
miRNA-CNV gene presences were observed to be biased in
male and female genomes in several populations (Figure 1c).
Africa, Tibet, JPT and Australia showed males (58–60%) to be
carrying more miRNA genes under CNVs than females (#40%),
while, CHB and India showed higher content in females (,60%)
compared to males (#40%). The remaining populations showed
balanced miRNA genes in both sexes, and New World population
did not contain female samples, but show the largest miRNA gene
content in males, whereas, Indian males showed the lowest
miRNA gene content under CNVs (Figure 3c).
miRNA-CNV Inheritance and Mutation rate
The miRNA-CNV rate analysis on trio families of YRI, CEU
and India, revealed three clusters of miRNA-CNVs based on
inheritance. CNVs with precise breakpoints inherited from one
generation to the next bearing the exact size and present in the
same location were regarded as ‘Inherited’ miRNA-CNVs.
miRNA-CNVs which were not identified in the first generation
but appeared in the second one with distinctly clear breakpoints
non-overlapping with other CNVs were regarded as De novo
miRNA-CNVs. The third cluster contained CNVs which showed
atleast one breakpoint (either start point or end point) being
precisely inherited, and the other non-inherited, but extended
breakpoint was considered as de novo, collectively they were
referred to as ‘‘Unknown’’. Of the 3,103 CNV calls examined
1160 CNV breakpoints were identified in the probands. Of these,
175 were assigned as inherited and 668 were de novo CNVs The
remaining 298 were the unusual ‘Unknown’ CNV events for
which a single parental origin could not be assigned. 53 miRNA-
CNVs from 1160 CNV breakpoints were further used to study the
miRNA-CNV inheritance and de novo mutation rate. YRI showed
8% of the miRNA-CNVs being inherited, while India showed
nominal rate of 4.7% and CEU did not contain any inherited
miRNA-CNVs. However, de novo mutation rate was high for YRI
and CEU while, the third cluster showed unequal rates with CEU
being the highest (37.5%) followed by YRI (16.6%) and India
(14.2%). The inherited miRNA-CNVs clustered above based on
the point and type of origin showed contributions only from the
maternal origin.
The investigation on miRNA-CNV hotspot rates is also critical
in understanding the CNV mutation rate and genomic instability
in the etiology of the miRNA regulated traits. The entire 4007
miRNA-CNV calls were used as an input to detect recurrent and
unique copy number regions based on percent overlap. miRNA-
CNV Hotspots were observed in chromosomes 22, 16, 15, and 3
whereas, chromosomes 13, 5 and 6 showed fewer hotspot CNVs.
Unique and intermediate events were distinctively found across all
chromosomes of the populations.
Minor Allele Frequency (MAF) of miRNA genes
We identified 16 miRNA genes to be under tremendous burden
of CNVs across all populations. These miRNA genes were found
in varying frequency (1–15.3%) under several miRNA-CNV
breakpoints, both within and across populations (Table 2).
Though, both duplications and deletions were observed for these
genes, however, duplications were more prevalent. These miRNA-
CNV breakpoints were identified starting from nine populations
upto six populations as we did not find any miRNA breakpoints
Figure 5. Complexities of miRNA CNV effect on genes. Representation of the different levels of complexities (a–h) present in the genome as a
result of CNV influence on the miRNA genes, their targets and protein interactors. The ‘+’ and ‘2’ sign beside each gene indicates the CNV type of
duplication and deletion, ‘‘I’’ and ‘‘P’’ indicates the overlapping status of CNVs and the numerical indicate the CN state.
doi:10.1371/journal.pone.0090391.g005
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shared between 12 to 10 populations. A total of 18 singleton
breakpoints were found across populations distributed in chromo-
somes 22, 15, 16 and 3. The highest global frequency (15.3%) was
observed for 14 miRNA-CNV breakpoints containing mir650
gene located in chromosome 22q11. The pair-wise clustering of
shared miRNA genes in percent across all chromosomes and 12
populations is represented in the Circos image (Figure S3).
CNV-miRNA Pathway
The miRNA genes which were found to be under severe CNV
burden are mir650, mir3179, mir3180, mir1324, and mir1233-2
along with 12 other miRNA genes. In the current study we made
use of Ingenuity Pathway Analysis (IPA) to identify the functional
processes of miRNA genes under the CNV load and to further
assess the possible phenotypic alterations in the population. IPA
revealed 23 diseases and disorders for various organ systems, and
these further contained 26 function-specific disease annotations
including the direct regulators of miRNAs and their target genes.
We identified a total of .112 proteins being regulated directly or
indirectly by .15 pre-miRNA molecules and ,15 mature
miRNA molecules. Several of these molecules were found to be
synergistic in both the regulation of various mRNA targets and in
causing diseases. We found a majority of the miRNAs to be
regulating several transcripts and a few proteins regulating specific
miRNAs. For instance, Tumor Necrosis Factor (TNF) regulates
both mir650 pre-miRNA and mature miRNA molecules. This
interlink of mir650 (pre-miRNA), TNF and mir3612 (mature
miRNA of mir650) were a major hub consisting of interlinking
proteins and more miRNA molecules further regulating the
downstream and upstream processes (Figure 4). Disruptions in
these processes were found to affect multiple processes resulting in
severe disease phenotypes, both common and rare. GGCX is
another hub which is regulated by vast amount of miRNA genes
and has functions related to immune system development. There
were several major and minor hubs in this CNV-miRNA pathway,
most of them were interlinked increasing the complexity of the
regulation.
Discussion
Identification of the miRNA-CNVs across diverse populations
helps understand the organization, distribution pattern of miRNA-
CNVs, evolutionary dynamics of the miRNA sub-genome, and
account for differences in the expression of genes. There have been
only few miRNA-CNV investigations on the CNVs obtained
through bioinformatic identification from several databases [12]
and HapMap populations [9]; however, there have not been
many, which comparatively include populations across all
continents to study notable variations on the genome, particularly
on genes using different ethnic backgrounds. The current study
represents the first drafts of population-specific miRNA-CNVs
maps as well as a cross-populational map. Here we present a
comprehensive global miRNA-CNV spectrum by identifying 333
singleton miRNA genes from total of 6542 miRNA genes from
4007 miRNA-CNVs across 12 populations using Affymetrix high
resolution arrays. The CNVs identified in this study are highly
consistent, because of the higher stringency adopted in both the
selection and validation of CNVs using multiple algorithms.
Although these samples are well characterized, no medical
information (except for HapMap) was obtained. The miRNA
genes and CNVs were co-active and conferred tremendous burden
in the regulation of the coding genome. Genetic diversity in
humans affects both disease and normal phenotypic variation.
Presence of CNVs alters the transcriptional and translational levels
of overlapping or nearby genes by disrupting the coding structure
or by altering gene dosage thereby conferring differential
susceptibility to complex diseases [28–34] and presence of
miRNA-CNVs further adds to the complexities on the regulation
and coding structure of the genome.
We detected gradual increase in the miRNA-CNV counts from
the Old World populations towards the New World populations
(Bolivians and Totanacs) indicating selective pressure of CNV
occurrences in New World populations contributing to increased
genetic diversity. miRNA-CNVs can considerably alter their
dosage, which would then affect the expression levels of the target
genes [3,28,35–38]. We identified both miRNA and non-miRNA
duplication CNVs to be higher than deletion CNVs in several
populations, while only few populations showed increased
deletions. The prevalence of higher miRNA-duplication CNVs
might be due to the lesser damage it offers by protecting against
deletions [38]. Though, duplication CNVs have been associated in
many diseases, most of them are regarded due to partial
duplication disruptions of the coding gene. No consistent pattern
was identified for the miRNA duplication CNV distribution across
ethnicities since extremes of both CNV types were found elevated
in ethnic groups residing within the continental boundaries. Wu
et al. [9] observed CNVs in the miRNA regions of the HapMap
populations, and their data significantly overlaps with our findings
of CNVs in HapMap populations which indicates that the CNVs
identified in this study are highly consistent. The observations of
Wu et al. [9] and Marcinkowska et al. [12] greatly differed with
our findings and were not comparative across all study popula-
tions.
Chromosome-wise distribution of miRNA-CNVs
Chromosome 22 harbors high concentration of miRNA-CNVs
followed by chromosomes 15 and 16. The reason behind such
chromosomal selection for miRNA-CNVs to frequent is largely
speculative. These three chromosomes contain three miRNA
genes, namely, mir650 in chromosome 22, mir1233-2 in
chromosome 15 and mir3179/80 in chromosome 16. These genes
were found largely under CNVs across all populations, however,
population specific miRNA-CNV presences were also observed for
India, Tibet and New World. Several miRNA-CNVs have been
implicated in pathways, phenotypes and diseases [15,39–42] while
various miRNA-CNVs are found to be either deleted or
duplicated in diverse types of cancers [43–48]. The observed
varied dominance of chromosomal miRNA-CNVs may help in
understanding the molecular basis of human phenotypic diversity.
We observed higher duplication events than deletions in several
studies [9,12]; similarly the genes under these CNVs also tend to
be overrepresented in duplication CNVs compared to deletion
CNVs. New World showed higher gene content in miRNA
duplication CNV events, while gene overrepresentation in deletion
CNVs were limited to only China and Japan. These indicate the
genetic relationships and diversity between and within populations
and thus we propose that miRNA-CNVs are inherent variants and
should be considered as probable candidates while performing
genotype-phenotype association studies.
miRNA-CNV size and miRNA-CNV count distribution devi-
ated significantly across population and revealed contrasting
contributions towards the burden of CNVs. Though we found
duplication miRNA-CNVs to be overrepresented than deletion
CNVs, however, further analysis on miRNA-CNV size, revealed
larger size deletions to be encompassing miRNA genes compared
to duplication CNVs while only few populations were found with
high duplication sized miRNA-CNVs. This probably indicates
that, CNV type, count and size factors are independent of each
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other and should be collectively analyzed to understand the
complexities of miRNA in populations.
Ashkenazi Jews, JPT and Taiwan contained the highest number
of singleton miRNA genes under CNVs, than the remaining
populations. The inconsistency in total miRNA genes distribution
against singleton miRNA gene counts across chromosomes was
observed due to the regular frequenting of CNVs in regions
bearing one gene across many individuals in all populations and
was not due to the presence of multiple miRNA genes and this
pattern was observed across many chromosomes within the
populations.
Sex bias
Gender plays a pivotal role in the human genetic identity and is
also manifested in many genetic disorders. miRNA-CNV presence
showed sex bias in several populations, largely dependent on
ethnicity. There was a significant difference in miRNA gene
distribution under CNVs in both male and female genome. These
findings imply gender based phenotypic differences. Many human
genetic phenotypes, including those related to olfaction, develop-
mental delay and intellectual disabilities have shown similar sex
bias along with recombination rates [49–50].
It was necessary to evaluate the zygosity nature of all the
identified miRNA-CNVs to accurately assess the genome changes
in order to correlate with duplication and deletion events.
HapMap and China showed significant losses in the miRNA
sub-genome with increased 0 and 1 deletion CN states, while
remaining populations showed higher duplication CN state of 3
and 4 indicating homozygous gain of parts of miRNA sub-
genome. Australia exhibited burden of miRNA-CNVs on sex
chromosomes compared to any other population, which indicates
the phenotypic differences of the Australian population can largely
be attributed to the miRNA genes present on sex chromosomes.
No distinct pattern could be derived from the observed CN states
of all the populations, since they all exhibited differences even with
shared ethnicities. Comparison of the 5 CN states of the non-
miRNA CNVs with the CN states of miRNA-CNVs revealed
striking similarities indicating that the miRNA sub-genome is
under the force of CNV dynamics of the genomes and that the
miRNA sub-genome does not seem to show any independent force
acting on it.
Based on the inheritance status, YRI showed a fold higher
inheritance rate compared to India, whereas CEU did not show
any inheritance of miRNA-CNVs. The rate of de novo CNV
occurrences were similar, while ‘‘Unknown’’ cluster showed
unequal rates with YRI being the highest, followed by CEU and
India. The reasoning and the mechanism on the origin of
‘‘Unknown’’ CNVs is yet to be clearly understood. All the
miRNA-CNVs clustered based on the point and type of origin
showed biased contributions of miRNA-CNVs from mother
compared to father. Though, earlier studies have reported diverse
CNV transmission and de novo event rates in probands with several
neurodevelopmental phenotypes and monozygotic twin studies
[51–54], however, no such inheritance rate on the miRNA-CNVs
has been performed before. miRNA-CNV frequency bias was
observed on the CNV transmissions from maternal genome only,
showing major contributions from deletion CNVs than duplica-
tions. We believe the existence of such biased transmissions greatly
signifies the role of parental transmission in gene regulation and
counters some distinct phenotypic features observed in previous
studies [55–56] and in certain gender-specific disease manifesta-
tions.
Hotspot Detection
Hotspot analysis was performed using HD-CNV to identify the
hotspots and unique CNVs between samples of the same and other
populations and to also correlate their abeyant effects on a wide
variety of regulatory pathways. HD-CNV program was used on
3958 miRNA-CNV events revealing hotpot, rare and intermediate
miRNA-CNV regions between samples of the same and other
populations. Unique CNV events were considerably higher
compared to hotspots and intermediate events, and almost all
events were found overlapping with atleast one other event. These
events are very commonly recurring events that have similar
boundaries and not much distinction can be observed in the
groups. Chromosomes 22, 16, 15 and 3 shows highly conserved
patterns, as there are large groupings of overlapping CNV calls,
and very few individual calls. The locus-specific mutation rates for
CNV have been observed to be ,100 to 10,000 times higher than
those for nucleotide substitution rates, which not only highlights
the instability of CNV regions but also suggests large variation in
CNV mutation rate [57]. The data from the 1000 Genomes
Project suggest that the distribution of CNVs in the genome is
biased towards multiple hotspots including segmental duplications
and away from genes encoding protein complexes and other
dosage sensitive genes [58]. Contrary to this, our data suggests
miRNA-CNV distribution in regions of the genome bearing
miRNA genes regulating protein complexes and dosage sensitive
genes. Hotspot analysis further elucidated the fragility of the
miRNA sub-genome which contains recurrent CNV regions
bearing large concentration of repeats in the flanking sequences.
Some of these recurrent CNV regions are the probable reason
behind several miRNA genes showing high copy numbers across
populations.
Around 16 singleton miRNA-CNVs from a total of 4007
miRNA-CNVs are identified across chromosomes in all popula-
tions at varying frequencies. Many of the HapMap miRNA-CNVs
identified here are found in previous investigations [59], this hence
validates the ability of our arrays to detect reliable variations. Our
analysis of different populations allowed an assessment of
population-specific miRNA-CNVs. These CNVs across multiple
ethnic populations suggest that these structural rearrangements
confer phenotypic diversity to a great extent.
miRNA-CNVs Functional and Disease Pathway
We computed a network for the individuals containing CNVs in
both miRNA genes and in their protein-coding gene targets to
quantify burden and to determine variability within and between
populations. We selected the 16 miRNA genes that were heavily
burdened by CNVs and established a regulatory network involving
miRNAs, their targets and the target’s interacting partners.
Assessing relatedness between the miRNA molecules revealed
mechanisms that influenced disease susceptibility and phenotype
expression (Table 3).
mir650 plays a key role in the manifestation of several cancers
such as chronic lymphocytic leukemia (CLL) [60], colorectal [61],
gastric cancer [62] and hepatocellular carcinoma (HCC) [63],
furthermore, studies have also implicated dysregulation of mir650
in patients of diabetic ischemic heart failure [64] and multiple
sclerosis. mir650 is known to be directly regulated by TNF, which
are a group of cytokines which cause apoptosis. Upregulation of
mir650 down-regulates processes of ING4 favoring HCC tumor-
igenesis, while it targets ING4, cyclin dependent kinase 1 (CDK1)
and early B-cell factor 3 (EBF3) molecules towards CLL prognosis.
mir3179/80, mir1324 and mir1268a are all found regulating
ZNF579 target, while mir3180, mir3612 and mir1286 also
regulate C6orf15, whereas TNF regulates mir3612. Overexpres-
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sion of mir3179 has been implicated along with slightly altered
TNF and IL-6 levels in Tuberculosis (TB) group compared to
controls [65]. mir1286 down regulates C6orf15 and MMEL1; and
alteration at these processes favor rheumatoid arthritis, and
development and fertilization of ova. mir3179 and vast amount
of other miRNA molecules such as mir338, mir3118, mir657,
mir1268 and mir650 down regulates GGCX, and sometimes these
down-regulators are regulated by other miRNA molecules such as
mir650 which is master regulator controlling the GGCX
downstream pathway, which also has been implicated in several
disease processes such as pulmonary embolism, thrombosis of vein,
abdominal hemorrhage and bleeding of tissue. mir675 is shown to
up-regulate the essential cartilage matrix component COL2A1
essential in cartilage regeneration [66], while both H19 and
mir675 are found to be upregulated in human colon cancer and
primary human colorectal cancers [67]. These miRNA and target
pathways are altered by disrupting or amplifying certain linear
pathways by the occurrences of miRNA-CNVs influencing gene
expression through different mechanisms such as, position effect,
deletion or duplication of regulatory elements, and through
variability of dosage. CNVs overlapping different parts of miRNA
genes such as whole gene amplification increase the dosage; on the
contrary, partial gene duplications and deletions can increase or
decrease the dosage of miRNAs. This complex regulatory network
consisting of CNV-miRNAs tend to target a higher average
number of target genes and favors to synergistically regulate the
same genes.
Genotypic complexities provided by miRNA-CNV genes
and its targets’ network
A number of miRNA genes and its target partners are found to
be under the burden of CNVs in individuals from New World,
Australia and Tibet. Six miRNA genes and six targets are found
disrupted by CNVs from an individual from New World, whereas,
the individual from Australia showed disruption of several miRNA
such as mir519b, mir526b, mir519d, mir519a, and mir519c and
its target gene PDCD1LG2, furthermore mir526b and mir877 are
disrupted along with its target ARHGAP26. In an individual from
Tibet, mir517b, mir517a, and mir517c along with its target gene
DBN1 are under the CNVs, further, mir3180-1, mir3180-2, and
mir3180-3 and its target genes CD44 and FAM115A in the same
individual are disrupted. A total of .100 miRNA genes and .500
target partners are identified in individuals from different
populations to be under the direct burden of both duplication
and deletion CNVs (Figure 5).
Variations bearing miRNAs cause diseases because of their
failure to silence their target genes and since miRNAs have
multiple targets, it is expected that they have a collective action
over cell functionalities. To characterize the efficacy of miRNA-
CNVs on regulation, we have identified several mechanisms for
selected miRNAs to determine potential functional effect. These
mechanisms are represented on a miRNA-CNV, miRNA-Target
and, Target-interacting proteins network which helps in the better
understanding of complexities of the CNVs in miRNA gene
regions. Studies on the implications of CNVs on disease genes
have been extensively performed; however, the layers of
complexities remain unidentified. Although, there have been
numerous investigations to find the influence of CNVs on gene
expression phenotypes, however, only a few of them have
effectively been able to associate them with diseases [68], while
most part of it remains to be explored to understand phenotypic
differences.
In the present investigation, several layers of complexities
created due to the presence of multiple CNVs across many
miRNA gene regions, which regulate gene targets within a
genome, are extensively studied to unravel the complex mecha-
nism of miRNA-CNVs towards the phenotypic diversity. This was
performed by identifying the miRNA genes and their targets
disrupted by the presence of CNVs. The following CNV-
complexities were identified in the genomes of individuals: (i)
CNVs disrupted the coding structure of ,5 to .25 miRNA genes
either by duplications or deletion of the entire or partial genes, (ii)
The presences of CNVs in the genomic regions of the target genes
of the above identified miRNA in the same individual, (iii) other
miRNA genes under the CNVs which share similar target genes,
(iv) CNVs truncating the coding structure of the immediate
interacting protein partners of the miRNA targets as well as the
miRNA genes disrupted through CNVs (Figure S4). For instance,
CNVs were found to be disrupting the miRNA genes mir1324,
mir1283, and mir520d in an individual, some of the miRNA
targets which are shared between these disrupted miRNA genes
were also found to contain a common miRNA target ‘NEDD9’
which was also under the influence of CNV. mir1283 down-
regulates targets OLR1, CPEB4, and DUSP1, which are all under
the influence of CNVs, further mir520d and mir524 also regulate
MXD1. DUSP1 and NEDD9 are predicted to physically interact
through DLGAP2 intermediary. Instances such as these were
found in the genomes of many individuals. The layers of CNV
complexities amplify with the increase of CNVs in either the target
genes or the regulating genes.
This complex relationship of CNVs on miRNA-genes and its
target partners unravels the complexities involved in gene function
and phenotypic expression. We propose four different types of
mechanisms which create the complexity in gene regulation
indicating that multiple miRNA-CNVs, targets and their protein
partners are potential functional variants. Therefore these
proposed mechanisms should be considered as potential candi-
dates while performing genotype-phenotype association and gene
regulation studies. This complex relationship of CNVs on miRNA
genes and their target partners unravels the many complexities
involved in transcriptional regulation and phenotype expression.
Supporting Information
Figure S1 Chromosome-wise distribution of CNV bur-
den across 12 populations. a) Represents total percent of
miRNA CNVs and b) represents the percent distribution of CNV
size. Each cluster consists of 12 bars, each bar indicating a specific
population.
(TIF)
Figure S2 Chromosome-wise distribution of miRNA
genes (in percent) across 12 populations. (a) represents
the total 6542 miRNA gene distribution across chromosomes and
populations (b) is the 333 singleton miRNA gene distribution
across chromosomes and populations. Each cluster consists of 12
bars and each bar indicates a specific population.
(TIF)
Figure S3 miRNA CNV-gene map. The outermost to
innermost tracks represent the pair-wise clustering of total miRNA
genes shared across all chromosomes and populations in this
Circos image.
(TIF)
Figure S4 The interaction complexity of miRNA CNV in
function and/or disease in an individual. miRNA genes
interact with their specific target resulting in the disease and/or
specific phenotype. CNV influencing the miRNA genes and their
targets in the same individual may disrupt or alter the normal
CNV Burden on miRNA Genes
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mode of interactions. Further, the CNV influence on protein
interactors of the miRNA targets adding to the level of interaction
complexity in the individual.
(TIF)
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